*NOTE: This study is closed/manuscript in progress*
The aim of this study is to evaluate client perception of quality of life improvement in Labrador Retrievers with laryngeal paralysis (LP) given doxepin for one month compared to dogs given placebo.
Labrador Retrievers with clinical signs consistent with non-critical LP. To be evaluated for enrollment, dogs will have initial history and physical exam. If considered likely to have LP, dogs will have routine hematologic, biochemical, and thyroid evaluation.
Reduced initial exam charge. No charge for blood work, echolaryngography, neurologic evaluation, and study medication for enrolled dogs. The client is responsible for all other charges. A $100 account credit will be given at completion of study.
Jill Sammarco, BVSc, MRCVS, DACVS
RBVH Surgery Department (Tinton Falls)
(732) 747-3636
Eric N. Glass, MS, DVM, DACVIM (Neurology)
RBVH Neurology & Neurosurgery Department
(732) 747-3636